Dean X. Parmelee, M.D., Associate Dean
|
|
Catherine A. Sheffield, Pharm.D., BCPS
Director, Therapeutics Curriculum
|
|
Education and Certifications |
|
|
Pharm.D., Albany College of Pharmacy, 2006 Adult Medicine/Endocrinology Residency, The Endocrine Group/Albany College of Pharmacy, Albany, New York, 2007 |
|
|
Board Certified Pharmacotherapy Specialist, 2009 |
|
|
Professional Memberships and Activities |
|
|
Journal reviewer: The Annals of Pharmacotherapy, 2008 - Present; and The Journal of Pharmacy Technology, Ohio Society of Health-Systems Pharmacists, 2008 - Present American Society of Health-Systems Pharmacists, 2006 - Present American College of Clinical Pharmacy, 2006 - 2009, 2011- Present
American Pharmacists Association, 2006 - 2008 Pharmacists Society of the State of New York, 2006 - 2008 |
|
|
Publications and Research |
|
|
Sheffield CA, Kane MP, Bakst G, Busch RS, Abelseth JM, Hamilton RA. Accuracy and precision of four value-added blood glucose meters: the Abbott Optium, the DDI Prodigy, the HDI True Track, and the HypoGuard Assure Pro. Diabetes Technol Ther. 2009 Sep;11(9):587-92. Sheffield CA, Kane MP, Busch RS, Bakst G, Abelseth JM, Hamilton RA. The safety and efficacy of exenatide in combination with insulin in patients with type 2 diabetes. Endocrine Practice. 2008;14(3):285-92. Sheffield CA, Kane MP, Busch RS. Off label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with Human Immunodeficiency Virus infection. Pharmacotherapy. 2007;27(10):449-55. “A glucose meter accuracy and precision comparison: the Freestyle Lite versus the Accu-Chek Aviva, Accu-Chek Compact Plus, Accu-Chek Advantage, Ascensia Contour, BD Logic, and the LifeScan Ultra2” The Endocrine Group, Albany, NY (Data collected for Abbott Diabetes Care) 2007. |
|
|
Presentations |
|
|
"Medication Safety Update: Focus on Recent FDA Alerts," October 2011. Presented to Dayton VAMC. Advanced Practice Nursing Group, Dayton VAMC, Dayton, OH. “Lipid Management,” February 2011. Presented to Dayton VAMC Medical Staff and Residents at Noon Conference. Dayton VAMC., Dayton, Ohio. “Diabetes Update: Neuroendocrine Drugs,” September 2009. Presented to Dayton VAMC Advanced Practice Nursing Group. Dayton VAMC, Dayton, Ohio. “Inpatient Hyperglycemia Management,” May 2009. Presented with Brian Burke, MD, FACP, and Uthona Green, CNS, at Grand Rounds. Green Memorial Hospital, Xenia, Ohio. "Glucose meter accuracy study: correlation of the Yellow Springs Instrument with December 2008 venous laboratory glucose measurements and popular plasma-calibrated glucose meters." Presented with Andrea Traina, Pharm.D. at the ASHP Midyear Clinical Meeting, Orlando, Florida. "An Overview of Diabetes Mellitus for Mental Health Professionals," November 2008. Presented with Brian Burke, MD, FACP, Psychiatry Grand Rounds, Dayton V.A.M.C., Dayton, Ohio “Weighing in on type 2 diabetes management: weight control vs. blood glucose control," April 2008. Presented to pharmacists at “Clinical Controversies” CE program. Albany College of Pharmacy, Albany, New York “Accuracy and precision of four value-added blood glucose meters: the Abbott October 2007 Optium, the DDI Prodigy, the HDI True Track, and the Hypoguard Assure-Pro.” Poster selected as Runner-Up in the Resident/Fellow Research Poster Competition at the ACCP Annual Meeting, Denver, Colorado. “Long-term safety and efficacy of off-label exenatide in patients with type 2 diabetes,” December 2006. Poster presented to attendees of the ASHP Midyear Clinical Meeting, Anaheim, California. “Medication Reconciliation,” October 2005. Presented at Grand Rounds to the staff of Ellis Hospital, Schenectady, New York. |
|
|
|
|
